Cure My Disease

Don't miss your cure!

 Log in / Sign up

Drug watch: tracking Xolair's Real-World impact on nasal polyps

NCT ID NCT05626257

Completed Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study monitored the safety and effectiveness of Xolair in adults with chronic sinusitis and nasal polyps who weren't fully helped by standard nasal sprays. It followed 135 Korean patients in their regular doctor's visits for 24 weeks to track any side effects and see if their symptoms and quality of life improved. The goal was to understand how the medication performs in everyday medical practice, not to test a new treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Novartis Investigative Site

    Anyang-si, Gyeonggi-do, 14068, South Korea

  • Novartis Investigative Site

    Bundang Gu, Gyeonggi-do, 13620, South Korea

  • Novartis Investigative Site

    Uijeongbu-si, Gyeonggi-do, 11759, South Korea

  • Novartis Investigative Site

    Incheon, Korea, 405 760, South Korea

  • Novartis Investigative Site

    Seoul, Korea, 03080, South Korea

  • Novartis Investigative Site

    Seoul, Korea, 03312, South Korea

  • Novartis Investigative Site

    Seoul, Korea, 07061, South Korea

  • Novartis Investigative Site

    Seoul, Korea, 08308, South Korea

  • Novartis Investigative Site

    Seoul, Yangcheon gu, 07985, South Korea

  • Novartis Investigative Site

    Daegu, 705 718, South Korea

  • Novartis Investigative Site

    Gyeonggi-do, 14353, South Korea

  • Novartis Investigative Site

    Seoul, 03722, South Korea

  • Novartis Investigative Site

    Seoul, 06351, South Korea

  • Novartis Investigative Site

    Seoul, 07804, South Korea

  • Novartis Investigative Site

    Seoul, 2447, South Korea

  • Novartis Investigative Site

    Suwon, 16247, South Korea

Conditions

Explore the condition pages connected to this study.

CHRONIC RHINOSINUSITIS WITH NASAL POLYPS